SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form T-3 - Application for qualification of trust indentures:
SEC Accession No. 0001140361-19-013140
Filing Date
2019-07-18
Accepted
2019-07-19 13:50:43
Documents
9

Document Format Files

Seq Description Document Type Size
1 T-3 formt3.htm T-3 58669
2 EXHIBIT T3C.1 ext3c_1.htm EX-99.T3C.1 783411
3 EXHIBIT 25.1 ex25_1.htm EX-25.1 483741
4 image00006.jpg GRAPHIC 2201
5 image00007.jpg GRAPHIC 2578
6 image00008.jpg GRAPHIC 2706
7 image00009.jpg GRAPHIC 2701
8 image00010.jpg GRAPHIC 2324
9 image00011.jpg GRAPHIC 3453
  Complete submission text file 0001140361-19-013140.txt   1349618
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: T-3 | Act: 39 | File No.: 022-29077 | Film No.: 19963032
SIC: 2834 Pharmaceutical Preparations